LIN9 Antikörper (N-Term)
-
- Target Alle LIN9 Antikörper anzeigen
- LIN9 (Lin-9 Homolog (LIN9))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human, Maus, Ratte, Xenopus laevis
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LIN9 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Kreuzreaktivität
- Maus, Ratte (Rattus), Frosch
- Aufreinigung
- Purified
- Immunogen
- LIN9 antibody was raised in rabbit using the N terminal of LIN9 as the immunogen
- Top Product
- Discover our top product LIN9 Primärantikörper
-
anti-Lin-9 Homolog (LIN9) (AA 1-558) antibody
LIN9 Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-Lin-9 Homolog (LIN9) (AA 5-103) antibodyLIN9 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Lin-9 Homolog (LIN9) (AA 132-160), (N-Term) antibodyLIN9 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB36930 unconjugated
anti-Lin-9 Homolog (LIN9) (AA 1-558) antibodyLIN9 Reaktivität: Human IP Wirt: Kaninchen Polyclonal unconjugated
anti-Lin-9 Homolog (LIN9) (AA 155-204) antibodyLIN9 Reaktivität: Human, Maus, Affe, Ratte, Kaninchen, Rind (Kuh), Hund, Meerschweinchen, Pferd, Zebrafisch (Danio rerio), Huhn WB Wirt: Kaninchen Polyclonal unconjugated
anti-Lin-9 Homolog (LIN9) (AA 51-100) antibodyLIN9 Reaktivität: Human, Maus, Affe, Kaninchen, Rind (Kuh), Hund, Meerschweinchen, Pferd WB Wirt: Kaninchen Polyclonal unconjugated
anti-Lin-9 Homolog (LIN9) (AA 350-470) antibodyLIN9 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Lin-9 Homolog (LIN9) (N-Term) antibodyLIN9 Reaktivität: Human, Maus, Ratte, Zebrafisch (Danio rerio), Xenopus laevis, Huhn WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
LIN9 Blocking Peptide, catalog no. 33R-8618, is also available for use as a blocking control in assays to test for specificity of this LIN9 antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Konzentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Target
- LIN9 (Lin-9 Homolog (LIN9))
- Andere Bezeichnung
- LIN9 (LIN9 Produkte)
- Synonyme
- BARA antikoerper, BARPsv antikoerper, Lin-9 antikoerper, TGS antikoerper, TGS1 antikoerper, TGS2 antikoerper, 2700022J23Rik antikoerper, AA537062 antikoerper, AA545216 antikoerper, Bara antikoerper, si:dkey-206f10.4 antikoerper, wu:fb79c09 antikoerper, wu:fi32a10 antikoerper, zgc:153599 antikoerper, lin-9 DREAM MuvB core complex component L homeolog antikoerper, lin-9 DREAM MuvB core complex component antikoerper, lin-9 homolog (C. elegans) antikoerper, lin9.L antikoerper, LIN9 antikoerper, Lin9 antikoerper, lin9 antikoerper
- Hintergrund
- LIN9 belongs to the lin-9 family and acts as a tumor suppressor. It inhibits DNA synthesis. Its ability to inhibit oncogenic transformation is mediated through its association with RB1. LIN9 plays a role in the expression of genes required for the G1/S transition. Synonyms: Polyclonal LIN9 antibody, Anti-LIN9 antibody, lin-9 homolog, C. elegans antibody, BARA antibody, BARPsv antibody, Lin-9 antibody, TGS antibody, TGS1 antibody.
- Pathways
- Zellzyklus, Mitotic G1-G1/S Phases
-
